There wouldn’t be many who think Shanghai Model Organisms Center, Inc.’s (SHSE:688265) price-to-sales (or “P/S”) ratio of 5.4x is worth a mention when the median P/S for the Life Sciences industry in China is similar at about 4.6x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.
View our latest analysis for Shanghai Model Organisms Center
What Does Shanghai Model Organisms Center’s Recent Performance Look Like?
It looks like revenue growth has deserted Shanghai Model Organisms Center recently, which is not something to boast about. It might be that many expect the uninspiring revenue performance to only match most other companies at best over the coming period, which has kept the P/S from rising. If you like the company, you’d be hoping this…
